Effects of the POMC System on Glucose Homeostasis and Potential Therapeutic Targets for Obesity and Diabetes.
Dan YangXintong HouGuimei YangMengnan LiJian ZhangYunfeng LiuYi ZhangYunfeng LiuPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)
The hypothalamus is indispensable in energy regulation and glucose homeostasis. Previous studies have shown that pro-opiomelanocortin neurons receive both central neuronal signals, such as α-melanocyte-stimulating hormone, β-endorphin, and adrenocorticotropic hormone, as well as sense peripheral signals such as leptin, insulin, adiponectin, glucagon-like peptide-1, and glucagon-like peptide-2, affecting glucose metabolism through their corresponding receptors and related signaling pathways. Abnormalities in these processes can lead to obesity, type 2 diabetes, and other metabolic diseases. However, the mechanisms by which these signal molecules fulfill their role remain unclear. Consequently, in this review, we explored the mechanisms of these hormones and signals on obesity and diabetes to suggest potential therapeutic targets for obesity-related metabolic diseases. Multi-drug combination therapy for obesity and diabetes is becoming a trend and requires further research to help patients to better control their blood glucose and improve their prognosis.
Keyphrases
- type diabetes
- glycemic control
- blood glucose
- insulin resistance
- weight loss
- metabolic syndrome
- cardiovascular disease
- high fat diet induced
- weight gain
- end stage renal disease
- signaling pathway
- newly diagnosed
- ejection fraction
- adipose tissue
- emergency department
- peritoneal dialysis
- skeletal muscle
- spinal cord
- blood pressure
- oxidative stress
- risk assessment
- patient reported outcomes
- prognostic factors
- brain injury
- blood brain barrier
- body mass index
- drug induced
- human health